Study S001708

Pilot Study for Evaluation of the Impact of Intensive Short-Term Drug Therapy on Beta-Cell Function and Insulin Resistance in Patients With Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04027023
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 9
Start: 2019-10-30
Primary completion: 2021-04-30
Lead sponsor: Sciema UG
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Diabetes mellitus Type 2 De-escalation treatment (DET)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

impact of a temporary personalized poly-pharmaceutical treatment on the disease stage in patients with type 2 diabetes [12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.